Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(47 intermediate revisions by 5 users not shown)
Line 5: Line 5:
If empty (no name is present), please volunteer to create content for that disease!
If empty (no name is present), please volunteer to create content for that disease!


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
__TOC__
<br />
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
Line 19: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
====CHAPTER 2 (SOFT TISSUE TUMOURS)====
|
----
|
----
|
----
|
|
|Alanna Church
----
|
|
----
|
|
|-
----
|Ewing Sarcoma
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
----
|
|
|Working with Eric McGinnis
----
|
|
|2021 template added
----
|-
|}<br />
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Lipoma|Lipoma]]
|[[STBT5:Lipoma|Lipoma]]
Line 160: Line 148:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
Line 229: Line 226:
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|Minimal genetic content added
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|
|
|
|
|
Line 236: Line 245:
|
|
|
|
|
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|Disease
|
|
Line 249: Line 268:
|
|
|-
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|Disease
|
|
Line 260: Line 288:
|
|
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|9/22/2025
|Katie Schieffer
|9/22/2025
|No genetic association
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 271: Line 310:
|
|
|-
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 282: Line 332:
|
|
|-
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 293: Line 343:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
Line 304: Line 354:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 315: Line 365:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 326: Line 376:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|Disease
|
|
Line 337: Line 407:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 348: Line 418:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 359: Line 440:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|Disease
|
|
Line 370: Line 451:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Kati
e Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|Minimal genetic content added
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
Line 381: Line 474:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 392: Line 485:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
Line 403: Line 496:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|
|
Line 414: Line 507:
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Yiting Li (trainee);
Shashirekha Shetty (mentor)
|9/24/2025
|12/24/2025
|COMPLETE
|12/18/2025
|Katie Schieffer
|12/18/2025
|
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 425: Line 539:
|
|
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 436: Line 561:
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|COMPLETE
|9/18/2025
|Katie Schieffer
|9/18/2025
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|Disease
|
|
Line 458: Line 595:
|
|
|-
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
Line 469: Line 606:
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|
|
Line 480: Line 617:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 491: Line 628:
|
|
|-
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Disease
|
|
Line 502: Line 648:
|
|
|-
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 513: Line 659:
|
|
|-
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|Disease
|
|
Line 524: Line 714:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 546: Line 736:
|
|
|-
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 557: Line 747:
|
|
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 568: Line 767:
|
|
|-
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 579: Line 778:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 590: Line 811:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 601: Line 822:
|
|
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
Line 612: Line 833:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 623: Line 844:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 634: Line 855:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 645: Line 866:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 656: Line 886:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 667: Line 897:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 678: Line 908:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 689: Line 930:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 700: Line 941:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 711: Line 952:
|
|
|-
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 722: Line 963:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 733: Line 974:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 744: Line 985:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 755: Line 1,005:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 766: Line 1,016:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 777: Line 1,027:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 788: Line 1,038:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 799: Line 1,049:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 810: Line 1,060:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 821: Line 1,071:
|
|
|-
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 832: Line 1,082:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 843: Line 1,093:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|Consider linking to CNS tumor book
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|Disease
|
|
Line 854: Line 1,146:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 865: Line 1,157:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 876: Line 1,168:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 887: Line 1,179:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 898: Line 1,190:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 909: Line 1,212:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 920: Line 1,223:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 931: Line 1,243:
|
|
|-
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 942: Line 1,254:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 953: Line 1,265:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 975: Line 1,300:
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 997: Line 1,322:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 1,008: Line 1,333:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|10/13/2025
|
|12/31/2025
|
|COMPLETE
|
|12/24/2025
|
|Katie Schieffer
|
|12/24/2025
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|Disease
|
|
Line 1,030: Line 1,355:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,041: Line 1,375:
|
|
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|1/12/2026
|
|4/12/2026
|
|PENDING
|
|
|
|
Line 1,052: Line 1,386:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,063: Line 1,397:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:PEComa|PEComa]]
|Disease
|Disease
|
|
Line 1,074: Line 1,408:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,085: Line 1,419:
|
|
|-
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,096: Line 1,430:
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|
|
|
|
|
----
|
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,129: Line 1,473:
|
|
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,140: Line 1,484:
|
|
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,151: Line 1,495:
|
|
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|-
|Disease
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
====CHAPTER 4 (BONE TUMOURS)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|
|
|-
|
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,173: Line 1,558:
|
|
|-
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,195: Line 1,602:
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,206: Line 1,613:
|
|
|-
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,217: Line 1,624:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/31/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
Line 1,227: Line 1,644:
|
|
|
|
|
|-
|-
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,239: Line 1,666:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,250: Line 1,677:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,261: Line 1,688:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,272: Line 1,699:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,283: Line 1,710:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,294: Line 1,721:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|
|
Line 1,305: Line 1,732:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,316: Line 1,743:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,327: Line 1,754:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,338: Line 1,765:
|
|
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|2/15/2026
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,360: Line 1,796:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,371: Line 1,807:
|
|
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,382: Line 1,818:
|
|
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|
|
Line 1,393: Line 1,829:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,404: Line 1,840:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,415: Line 1,851:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|
Line 1,426: Line 1,873:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|Disease
|
|
Line 1,437: Line 1,884:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,448: Line 1,904:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,459: Line 1,915:
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,470: Line 1,926:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,481: Line 1,937:
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,492: Line 1,948:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,503: Line 1,959:
|
|
|-
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|Disease
|
|
Line 1,514: Line 1,981:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,525: Line 2,023:
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,536: Line 2,056:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|Refer to lipoma and hibernoma pages in STBT book
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to leiomyosarcoma page in STBT book
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Disease
|
|
Line 1,558: Line 2,089:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to plasmacytoma page in heme book
|
|
|
|
|-
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|Disease
|
|
Line 1,589: Line 2,120:
|
|
|
|
|
|Refer to heme book
|-
|-
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''!!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
Line 1,611: Line 2,140:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|Disease
|
|
Line 1,622: Line 2,151:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
Line 1,952: Line 2,162:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
----
|
|
----
|-
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|[[STBT5:Enchondromatosis|Enchondromatosis]]
Line 1,989: Line 2,198:
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
Line 2,022: Line 2,231:
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"